214 related articles for article (PubMed ID: 25875797)
1. Primary and liver metastasis-derived cell lines from KrasG12D; Trp53R172H; Pdx-1 Cre animals undergo apoptosis in response to triptolide.
Sangwan V; Banerjee S; Jensen KM; Chen Z; Chugh R; Dudeja V; Vickers SM; Saluja AK
Pancreas; 2015 May; 44(4):583-9. PubMed ID: 25875797
[TBL] [Abstract][Full Text] [Related]
2. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.
Phillips PA; Dudeja V; McCarroll JA; Borja-Cacho D; Dawra RK; Grizzle WE; Vickers SM; Saluja AK
Cancer Res; 2007 Oct; 67(19):9407-16. PubMed ID: 17909050
[TBL] [Abstract][Full Text] [Related]
3. Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.
Kim ST; Kim SY; Lee J; Kim K; Park SH; Park YS; Lim HY; Kang WK; Park JO
BMC Cancer; 2018 Nov; 18(1):1103. PubMed ID: 30419860
[TBL] [Abstract][Full Text] [Related]
4. Autophagy in pancreatic cancer: an emerging mechanism of cell death.
Mujumdar N; Saluja AK
Autophagy; 2010 Oct; 6(7):997-8. PubMed ID: 20818166
[TBL] [Abstract][Full Text] [Related]
5. Role of Hsp-70 in triptolide-mediated cell death of neuroblastoma.
Antonoff MB; Chugh R; Skube SJ; Dudeja V; Borja-Cacho D; Clawson KA; Vickers SM; Saluja AK
J Surg Res; 2010 Sep; 163(1):72-8. PubMed ID: 20638672
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor effect of combined triptolide and ionizing radiation.
Wang W; Yang S; Su Y; Xiao Z; Wang C; Li X; Lin L; Fenton BM; Paoni SF; Ding I; Keng P; Okunieff P; Zhang L
Clin Cancer Res; 2007 Aug; 13(16):4891-9. PubMed ID: 17699869
[TBL] [Abstract][Full Text] [Related]
7. Triptolide-mediated cell death in neuroblastoma occurs by both apoptosis and autophagy pathways and results in inhibition of nuclear factor-kappa B activity.
Krosch TC; Sangwan V; Banerjee S; Mujumdar N; Dudeja V; Saluja AK; Vickers SM
Am J Surg; 2013 Apr; 205(4):387-96. PubMed ID: 23428154
[TBL] [Abstract][Full Text] [Related]
8. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.
Mujumdar N; Mackenzie TN; Dudeja V; Chugh R; Antonoff MB; Borja-Cacho D; Sangwan V; Dawra R; Vickers SM; Saluja AK
Gastroenterology; 2010 Aug; 139(2):598-608. PubMed ID: 20434451
[TBL] [Abstract][Full Text] [Related]
9. Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.
Banerjee S; Sangwan V; McGinn O; Chugh R; Dudeja V; Vickers SM; Saluja AK
J Biol Chem; 2013 Nov; 288(47):33927-33938. PubMed ID: 24129563
[TBL] [Abstract][Full Text] [Related]
10. Synergism of cytotoxicity effects of triptolide and artesunate combination treatment in pancreatic cancer cell lines.
Liu Y; Cui YF
Asian Pac J Cancer Prev; 2013; 14(9):5243-8. PubMed ID: 24175808
[TBL] [Abstract][Full Text] [Related]
11. Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3 epsilon.
Liu Y; Song F; Wu WK; He M; Zhao L; Sun X; Li H; Jiang Y; Yang Y; Peng K
Cell Biochem Funct; 2012 Jun; 30(4):271-8. PubMed ID: 22315045
[TBL] [Abstract][Full Text] [Related]
12. Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F.
Oliveira A; Beyer G; Chugh R; Skube SJ; Majumder K; Banerjee S; Sangwan V; Li L; Dawra R; Subramanian S; Saluja A; Dudeja V
Lab Invest; 2015 Jun; 95(6):648-659. PubMed ID: 25893635
[TBL] [Abstract][Full Text] [Related]
13. Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer.
Modi S; Kir D; Giri B; Majumder K; Arora N; Dudeja V; Banerjee S; Saluja AK
J Gastrointest Surg; 2016 Jan; 20(1):13-23; discussion 23-4. PubMed ID: 26503259
[TBL] [Abstract][Full Text] [Related]
14. MAPKs are not involved in triptolide-induced cell growth inhibition and apoptosis in prostate cancer cell lines with different p53 status.
Li W; Liu Y; Li XX; Yu Y; Wu JJ; Wang Q; Huo H; Wang LM; Yang L
Planta Med; 2011 Jan; 77(1):27-31. PubMed ID: 20607649
[TBL] [Abstract][Full Text] [Related]
15. A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.
Chugh R; Sangwan V; Patil SP; Dudeja V; Dawra RK; Banerjee S; Schumacher RJ; Blazar BR; Georg GI; Vickers SM; Saluja AK
Sci Transl Med; 2012 Oct; 4(156):156ra139. PubMed ID: 23076356
[TBL] [Abstract][Full Text] [Related]
16. Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1.
Nakazato T; Sagawa M; Kizaki M
Int J Oncol; 2014 Apr; 44(4):1131-8. PubMed ID: 24481531
[TBL] [Abstract][Full Text] [Related]
17. Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.
Lu N; Liu J; Liu J; Zhang C; Jiang F; Wu H; Chen L; Zeng W; Cao X; Yan T; Wang G; Zhou H; Lin B; Yan X; Zhang XK; Zeng JZ
PLoS One; 2012; 7(4):e35722. PubMed ID: 22545132
[TBL] [Abstract][Full Text] [Related]
18. Triptolide and Its Derivatives as Cancer Therapies.
Noel P; Von Hoff DD; Saluja AK; Velagapudi M; Borazanci E; Han H
Trends Pharmacol Sci; 2019 May; 40(5):327-341. PubMed ID: 30975442
[TBL] [Abstract][Full Text] [Related]
19. Triptolide inhibits cell proliferation and tumorigenicity of human neuroblastoma cells.
Yan X; Ke XX; Zhao H; Huang M; Hu R; Cui H
Mol Med Rep; 2015 Feb; 11(2):791-6. PubMed ID: 25354591
[TBL] [Abstract][Full Text] [Related]
20. Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma.
Brincks EL; Kucaba TA; James BR; Murphy KA; Schwertfeger KL; Sangwan V; Banerjee S; Saluja AK; Griffith TS
FEBS J; 2015 Dec; 282(24):4747-4765. PubMed ID: 26426449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
